Cargando…

A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats

Whereas, multiple vaccine types have been developed to curb the spread of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) among humans, there are very few vaccines being developed for animals including pets. To combat the threat of human-to-animal, animal-to-animal, and animal-to-human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tabynov, Kairat, Orynbassar, Madiana, Yelchibayeva, Leila, Turebekov, Nurkeldi, Yerubayev, Toktassyn, Matikhan, Nurali, Yespolov, Tlektes, Petrovsky, Nikolai, Tabynov, Kaissar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967242/ https://www.ncbi.nlm.nih.gov/pubmed/35372556 http://dx.doi.org/10.3389/fvets.2022.815978

Ejemplares similares

An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
por: Tabynov, Kairat, et al.
Publicado: (2022)

An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023)

Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters
por: Tabynov, Kairat, et al.
Publicado: (2023)

A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
por: Babayeva, Meruert, et al.
Publicado: (2022)

Cytokine response and damages in the lungs of aging Syrian hamsters on a high-fat diet infected with the SARS-CoV-2 virus
por: Fomin, Gleb, et al.
Publicado: (2023)

Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Artemisia Pollen-Induced Allergic Bronchial Asthma in a Mouse Model
por: Tabynov, Kairat, et al.
Publicado: (2022)

Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
por: Ryskeldinova, Sholpan, et al.
Publicado: (2021)

Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets
por: Tabynov, Kairat, et al.
Publicado: (2016)

Operationalizing Cooperative Research for Infectious Disease Surveillance: Lessons Learned and Ways Forward
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats
por: Mailybayeva, Aigerim, et al.
Publicado: (2017)

Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
por: Mailybayeva, Aigerim, et al.
Publicado: (2020)

The pathogenicity of swan derived H5N1 virus in birds and mammals and its gene analysis
por: Tabynov, Kairat, et al.
Publicado: (2014)

Editorial: Engineered Adjuvants and Carriers for an Animal Infectious Disease Vaccine
por: Renu, Sankar, et al.
Publicado: (2021)

Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs
por: Bugybayeva, Dina, et al.
Publicado: (2020)

Cooperative Research and Infectious Disease Surveillance: A 2021 Epilogue
por: Parekh, Falgunee K., et al.
Publicado: (2022)

A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model
por: Bugybayeva, Dina, et al.
Publicado: (2021)

Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages
por: Zhang, Lu, et al.
Publicado: (2021)

A Case History in Cooperative Biological Research: Compendium of Studies and Program Analyses in Kazakhstan
por: Yeh, Kenneth B., et al.
Publicado: (2019)

Genotyping of cows by LHCGR, FSHR loci, and determination of the level of ovulation depending on the expression of the studied genes
por: Sarybayev, Yktiyar, et al.
Publicado: (2023)

Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
por: Khosa, Celso, et al.
Publicado: (2017)

Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection
por: Tabynov, Kaissar, et al.
Publicado: (2014)

Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine
por: Zhugunissov, Kuandyk, et al.
Publicado: (2021)

Building Scientific Capability and Reducing Biological Threats: The Effect of Three Cooperative Bio-Research Programs in Kazakhstan
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2021)

Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
por: Bidokhti, Mehdi R.M., et al.
Publicado: (2019)

Juvenile‐onset motor polyneuropathy in Siberian cats
por: Crawford, Kelly C., et al.
Publicado: (2020)

Immunogenicity and safety of subunit influenza vaccines in pregnant women
por: Kostinov, Mikhail P., et al.
Publicado: (2018)

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
por: To, Albert, et al.
Publicado: (2018)

A viral subunit immunogen for porcine transmissible gastroenteritis
por: Gough, Patricia M., et al.
Publicado: (1983)

Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement
por: Khalaj‐Hedayati, Atin, et al.
Publicado: (2019)

Vectors, molecular epidemiology and phylogeny of TBEV in Kazakhstan and central Asia
por: Abdiyeva, Karlygash, et al.
Publicado: (2020)

Eight Years of Collaboration on Biosafety and Biosecurity Issues Between Kazakhstan and Germany as Part of the German Biosecurity Programme and the G7 Global Partnership Against the Spread of Weapons and Materials of Mass Destruction
por: Peintner, Lukas, et al.
Publicado: (2021)

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines
por: Endalew, Abaineh D., et al.
Publicado: (2019)

Perioperative changes in cardiac biomarkers in juvenile cats during neutering
por: Konishi, Keisuke, et al.
Publicado: (2022)

Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
por: Sundaram, Appavu K., et al.
Publicado: (2021)

Pharmacokinetics and Immunogenicity of Frunevetmab in Osteoarthritic Cats Following Intravenous and Subcutaneous Administration
por: Walters, Rodney R., et al.
Publicado: (2021)

Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine
por: Zakhartchouk, Alexander N., et al.
Publicado: (2007)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
por: Agnolon, Valentina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_144nbp3muvfpo1rrgk8ag9u98l